LEXICON PHARMACEUTICALS INC (LXRX) Stock Earnings & Estimates
NASDAQ:LXRX - US5288723027 - Common Stock
1.13 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 100K -66.67% | 1.204M 1,104.00% | 31.081M 2,481.48% | 28.815M -7.29% | 12.494M -56.64% | 28.186M 125.60% | 69.082M 145.09% | 176.73M 155.83% | 284.69M 61.09% | 421.31M 47.99% | 556.75M 32.15% | |
| EBITDA YoY % growth | -100.4M -15.67% | -171.196M -70.51% | -196.583M -14.83% | -181.476M 7.68% | -174.478M 3.86% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -100.8M -15.73% | -171.75M -70.39% | -197.117M -14.77% | -145.953M 25.96% | -148.151M -1.51% | -114.623M 22.63% | -128.801M -12.37% | -40.258M 68.74% | 66.617M 265.47% | 204.2M 206.53% | 390.62M 91.29% | |
| Operating Margin | -100,800.00% | -14,264.95% | -634.20% | -506.52% | -1,185.77% | -406.67% | -186.45% | -22.78% | 23.40% | 48.47% | 70.16% | |
| EPS YoY % growth | -0.61 0.00% | -0.80 -31.15% | -0.64 20.00% | -0.24 62.83% | -0.28 -19.38% | -0.21 25.65% | -0.14 33.96% | -0.11 19.53% | 0.18 263.64% | 0.56 205.56% | 1.07 90.91% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 56.93% | -0.08 12.17% | -0.09 -23.86% | -0.09 -967.00% | -0.08 -5.26% | -0.07 16.13% |
| Revenue Q2Q % growth | 2.988M 70.74% | 3.463M -86.96% | 765K -39.38% | 765K -97.35% | 2.346M -21.49% | 5.115M 47.70% |
| EBITDA Q2Q % growth | -28.78M 54.52% | -34.782M -8.01% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -22.898M 64.05% | -25.981M 20.64% | -32.943M -28.29% | -32.035M -957.47% | -29.621M -29.36% | -28.102M -8.16% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.01 105.88% | -0.08 | 0.09 | 112.65% |
| Q1 2025 Q2Q % growth | -0.07 65.00% | -0.10 | 0.03 | 29.61% |
| Q4 2024 Q2Q % growth | -0.09 55.00% | -0.13 | 0.04 | 30.70% |
| Q3 2024 Q2Q % growth | -0.18 14.29% | -0.17 | -0.01 | -7.28% |
| Q2 2024 Q2Q % growth | -0.17 22.73% | -0.19 | 0.02 | 11.66% |
| Q1 2024 Q2Q % growth | -0.20 -17.65% | -0.20 | 0.00 | 0.72% |
| Q4 2023 Q2Q % growth | -0.20 -25.00% | -0.22 | 0.02 | 9.75% |
| Q3 2023 Q2Q % growth | -0.21 -61.54% | -0.22 | 0.01 | 4.13% |
| Q2 2023 Q2Q % growth | -0.22 -37.50% | -0.18 | -0.04 | -23.43% |
| Q1 2023 Q2Q % growth | -0.17 -6.25% | -0.18 | 0.01 | 7.02% |
| Q4 2022 Q2Q % growth | -0.16 5.88% | -0.14 | -0.02 | -17.06% |
| Q3 2022 Q2Q % growth | -0.13 18.75% | -0.14 | 0.01 | 8.53% |
| Q2 2022 Q2Q % growth | -0.16 -23.08% | -0.16 | 0.00 | 0.30% |
| Q1 2022 Q2Q % growth | -0.16 -6.67% | -0.17 | 0.01 | 4.74% |
| Q4 2021 Q2Q % growth | -0.17 -325.00% | -0.19 | 0.02 | 8.76% |
| Q3 2021 Q2Q % growth | -0.16 -122.86% | -0.18 | 0.02 | 11.38% |
| Q2 2021 Q2Q % growth | -0.13 79.37% | -0.16 | 0.03 | 20.22% |
| Q1 2021 Q2Q % growth | -0.15 76.19% | -0.16 | 0.01 | 6.57% |
| Q4 2020 Q2Q % growth | -0.04 91.67% | -0.28 | 0.24 | 85.82% |
| Q3 2020 Q2Q % growth | 0.70 -66.82% | 0.27 | 0.43 | 160.20% |
| Q2 2020 Q2Q % growth | -0.63 -186.36% | -0.62 | -0.01 | -1.63% |
| Q1 2020 Q2Q % growth | -0.63 -200.00% | -0.71 | 0.08 | 11.08% |
| Q4 2019 Q2Q % growth | -0.48 | -0.79 | 0.31 | 39.00% |
| Q3 2019 Q2Q % growth | 2.11 | 0.74 | 1.37 | 183.84% |
| Q2 2019 Q2Q % growth | -0.22 | -0.08 | -0.14 | -180.11% |
| Q1 2019 Q2Q % growth | -0.21 | -0.23 | 0.02 | 7.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 28.866M 1,652.64% | 4.965M | 23.901M | 481.39% |
| Q1 2025 Q2Q % growth | 1.262M 11.68% | 1.441M | -179K | -12.42% |
| Q4 2024 Q2Q % growth | 26.554M 3,682.62% | 6.61M | 19.944M | 301.72% |
| Q3 2024 Q2Q % growth | 1.75M 980.25% | 2.988M | -1.238M | -41.43% |
| Q2 2024 Q2Q % growth | 1.647M 419.56% | 2.887M | -1.24M | -42.95% |
| Q1 2024 Q2Q % growth | 1.13M 4,608.33% | 1.429M | -299K | -20.92% |
| Q4 2023 Q2Q % growth | 702K | 1.267M | -565K | -44.59% |
| Q3 2023 Q2Q % growth | 162K | 2.101M | -1.939M | -92.29% |
| Q2 2023 Q2Q % growth | 317K | 68.003K | 248.997K | 366.15% |
| Q1 2023 Q2Q % growth | 24K | 33.997K | -9.997K | -29.40% |
| Q4 2022 Q2Q % growth | 51K | -51K | -100.00% | |
| Q3 2022 Q2Q % growth | 51K | -51K | -100.00% | |
| Q2 2022 Q2Q % growth | -100.00% | 51K | -51K | -100.00% |
| Q1 2022 Q2Q % growth | 51K | -51K | -100.00% | |
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | 200K -97.83% | 9.18K | 190.82K | 2,078.65% |
| Q1 2021 Q2Q % growth | -100.00% | 1.71M | -1.71M | -100.00% |
| Q4 2020 Q2Q % growth | 200K -97.70% | 112.2K | 87.8K | 78.25% |
| Q3 2020 Q2Q % growth | 6.6M -97.76% | 17.21M | -10.61M | -61.65% |
| Q2 2020 Q2Q % growth | 9.2M -5.15% | 9.006M | 194K | 2.15% |
| Q1 2020 Q2Q % growth | 8M -13.04% | 7.944M | 56K | 0.70% |
| Q4 2019 Q2Q % growth | 8.7M | 10.471M | -1.771M | -16.91% |
| Q3 2019 Q2Q % growth | 294.4M | 65.535M | 228.865M | 349.23% |
| Q2 2019 Q2Q % growth | 9.7M | 29.089M | -19.389M | -66.65% |
| Q1 2019 Q2Q % growth | 9.2M | 13.532M | -4.332M | -32.01% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 7.88% | 41.54% | 40.11% | 31.41% |
| Revenue | -40.45% | -48.33% | 104.25% | 193.04% |